X0306 4 2015-05-20 0 0001469443 Arcadia Biosciences, Inc. RKDA 0001338665 BISHOP TERRI C C/O MORAL COMPASS CORPORATION 4835 E. EXETER BLVD. PHOENIX AZ 85018 0 0 1 0 0001213138 SPERLING PETER V C/O MORAL COMPASS CORPORATION 4835 E. EXETER BLVD. PHOENIX AZ 85018 0 0 1 0 0001641775 Moral Compass Corp 4835 E. EXETER BLVD. PHOENIX AZ 85018 0 0 1 0 0001641769 John G. Sperling 2012 Irrevocable Trust No. 1 4835 E. EXETER BLVD. PHOENIX AZ 85018 0 0 1 0 0001641770 John G. Sperling 2012 Irrevocable Trust No. 2 4835 E. EXETER BLVD. PHOENIX AZ 85018 0 0 1 0 0001641772 John G. Sperling 2012 Irrevocable Trust No. 3 4835 E. EXETER BLVD. PHOENIX AZ 85018 0 0 1 0 Common Stock 2015-05-20 4 P 0 1000000 8.00 A 1160714 I By Moral Compass Corporation Common Stock 2015-05-20 4 C 0 15170451 0.00 A 16331165 I By Moral Compass Corporation Common Stock 2015-05-20 4 C 0 3847751 0.00 A 20178916 I By Moral Compass Corporation Common Stock 2015-05-20 4 C 0 2336448 0.00 A 22515364 I By Moral Compass Corporation Series A Convertible Preferred Stock 2015-05-20 4 C 0 60681805 0.00 D Common Stock 15170451 0 I By Moral Compass Corporation Series B Convertible Preferred Stock 2015-05-20 4 C 0 15391006 0.00 D Common Stock 3847751 0 I By Moral Compass Corporation Series C Convertible Preferred Stock 2015-05-20 4 C 0 9345794 0.00 D Common Stock 2336448 0 I By Moral Compass Corporation Terri Bishop and Peter Sperling both serve as directors of Moral Compass Corporation. Moral Compass Corporation is owned in equal amounts by the John G. Sperling 2012 Irrevocable Trust No. 1, the John G. Sperling 2012 Irrevocable Trust No. 2 and the John G. Sperling 2012 Irrevocable Trust No. 3 (the "Sperling Trusts"). Darby Shupp, a director of the Issuer, Terri Bishop and Peter Sperling together serve as the three trustees of the Sperling Trusts and have shared voting and investment power over the shares held by Moral Compass Corporation. Ms. Shupp's statement of changes in beneficial ownership of securities of the Issuer is reported on a Form 4 filed separately. The Series A Convertible Preferred Stock converted into the Issuer's Common Stock at a conversion ratio of one share of common stock for every four shares of preferred stock upon the closing of the Issuer's initial public offering of common stock, and had no expiration date. The conversion ratio reflected an adjustment due to the Issuer's 1-for-4 reverse stock split effected on May 8, 2015. The Series B Convertible Preferred Stock converted into the Issuer's Common Stock at a conversion ratio of one share of common stock for every four shares of preferred stock upon the closing of the Issuer's initial public offering of common stock, and had no expiration date. The conversion ratio reflected an adjustment due to the Issuer's 1-for-4 reverse stock split effected on May 8, 2015. The Series C Convertible Preferred Stock converted into the Issuer's Common Stock at a conversion ratio of one share of common stock for every four shares of preferred stock upon the closing of the Issuer's initial public offering of common stock, and had no expiration date. The conversion ratio reflected an adjustment due to the Issuer's 1-for-4 reverse stock split effected on May 8, 2015. /s/ Philip Peters, as Attorney-in-Fact for Terri Bishop 2015-05-21 /s/ Philip Peters, as Attorney-in-Fact for Peter Sperling 2015-05-21 /s/ Philip Peters, as Attorney-in-Fact for Moral Compass Corporation 2015-05-21 /s/ Philip Peters, as Attorney-in-Fact for John G. Sperling 2012 Irrevocable Trust No. 1 2015-05-21 /s/ Philip Peters, as Attorney-in-Fact for John G. Sperling 2012 Irrevocable Trust No. 2 2015-05-21 /s/ Philip Peters, as Attorney-in-Fact for John G. Sperling 2012 Irrevocable Trust No. 3 2015-05-21